Did you mean meditation dot dot dot?
Overview
Trintellix is a prescription drug approved by the Food and Drug Administration (FDA) to treat major depressive disorder. Trintellix is also referred to by its drug name, Vortioxetine. Trintellix was previously… read more
Overview
Spravato is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with treatment-resistant depression (TRD), either alone or in combination with an oral…
Overview
Abilify is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia, the acute treatment of manic and mixed episodes associated with bipolar 1 disorder, and as an adjunctive…
Overview
Abilify Maintena is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia and the maintenance monotherapy (single-drug treatment) of bipolar 1 disorder in adults. This…
Overview
Saphris is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia in adults and for the treatment of bipolar 1 disorder in both adults and children aged 10 to 17. For bipolar 1…
Overview
Vraylar is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia in adults. It is also approved for the acute treatment of manic or mixed episodes and depressive episodes…
Overview
Geodon is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia in adults, and for the treatment of manic or mixed episodes associated with bipolar 1 disorder. For bipolar 1…
Overview
Zurzuvae is approved by the U.S. Food and Drug Administration (FDA) to treat postpartum depression in adults. It’s prescribed for people experiencing depression after childbirth. Zurzuvae can be taken by itself…
The Zulresso brand name has been discontinued in the U.S.
Overview
Zulresso is approved by the U.S. Food and Drug Administration (FDA) for the treatment of postpartum depression (PPD) in people 15 and older. As of July…
Overview
Wellbutrin XL is approved by the U.S. Food and Drug Administration (FDA) for the treatment of major depressive disorder (MDD) and for the prevention of seasonal affective disorder (SAD). For individuals with MDD…
read more